Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients.
By L. Solbiati, T. Livraghi, S. Goldberg, T. Ierace, F. Meloni, M. Dellanoce, L. Cova, E. Halpern, G. Gazelle. Radiology, 2001
918 citations recorded by the source corpus.
Subfields: Biotechnology, Hepatology, Surgery
View Paper: https://www.semanticscholar.org/paper/d5e1809c0e0772d86ca61473f98619ae270d9406
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Surgery
Citations in the corpus
- Image-guided tumor ablation: standardization of terminology and reporting criteria. (2005, positive): “Many reports have surfaced in which different degrees of partial ablation have been reported (22,30,33, 73,74).”
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer (2009, positive): “Clinical trials showed high efficacy of RFA for liver lesions, especially from colorectal cancer with long-term local disease control ranging from 40% to 80%, depending on lesion size, and a prolonged overall survival in treated patients (1019,1020).”
- Local Recurrence After Hepatic Radiofrequency Coagulation: Multivariate Meta-Analysis and Review of Contributing Factors (2005, background): “One report described 64 patients with local recurrences, of which only 34 received re-treatment.(109) This report did not mention the success rate of re-treatment.”
- A Review of Basic to Clinical Studies of Irreversible Electroporation Therapy (2015, neutral): “recurrence after hyperthermia and cryosurgery is significant and reported in the clinical literature [138]–[140].”
- Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases (2004, background): “Three-year survival rate for RFA resection (42%) or RFA only (37%) is similar to that reported in the literature.(16,17) The present study is the first to our knowledge to compare outcome after RFA or RFA combined with hepatic resection to a studied control group and demonstrate an advantage over no”